HomeAbout UsContact Us
Advanced Search
All CoursesCourses by TopicCourses by SpecialtyCourses by Specialty CreditRegister Now!!
Register Now!!
Member Login
Your Account
Your Test History
Your Certificates
All Courses
Courses by Topic
Courses by Specialty
Courses by Specialty Credit
Featured Programs
Other Resources
Accreditation
FAQs
 
Home : Advanced Search : Course view






This course is no longer active as of 2005-11-30

Course: The Biologic Revolution in Rheumatoid Arthritis 


Specialty: Rheumatology Format: Text 
Course #: 1824  Price: FREE  
Release date: 2003-12-01  Valid through: 2005-11-30  
Course viewing requirements  (opens in a new window)
Instructions for Course Participation  (opens in a new window)
Legal disclaimer  (opens in a new window)


Target Audience:
This activity is designed for the rheumatologist and internist.
Sponsor:
This CME activity is sponsored by AHC Media, formerly Thomson American Health Consultants, Atlanta, GA.
Accreditation Statement:
AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation:
AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Subjects:
  • The Biologic Revolution in Rheumatoid Arthritis - Dr. Joan M. Bathon
  • The Biologic Revolution in Rheumatoid Arthritis - Steven B. Abramson, MD
 
Objectives:
  • Understand how advances in therapeutics have altered treatment of rheumatoid arthritis
  • Analyze the scientific evidence surrounding the use of TNF antagonists in the treatment of rheumatoid arthritis patients
  • Discuss the implications of the use of TNF antagonists in avoiding adverse events
  • Understand the role early treatment with DMARDs plays in disease progression
 
Financial Disclosure:
In order to reveal any potential bias in this publication, and in accordance with Accreditation Council for Continuing Medical Education guidelines, we disclose that Dr. Emery discloses that he is a clinical investigator and consultant for Schering Plough/Centocor, Wyeth-Ayerst, Amgen, Aventis, and Abbott. Dr. Keystone discloses that he is a consultant for Schering, Wyeth-Ayerst, has received research grants from Centocor, and is on the speakers' bureau for Immunex. Dr. Fox discloses that he receives research funding from the National Institutes of Health and the Arthritis Foundation. Dr. Abramson discloses that he has received grant support from the National Institute for National Institute of Arthritis and Musculoskeletal and Skin Diseases and the Arthritis Foundation. He has received speaker's honoraria or consulting fees from Pfizer, Amgen, Novartis, and Pharmacia. Dr. Bathon discloses that she receives funding for clinical grants from Immunex, Hoechst Marion Roussel, Searle, and Bayer. She holds financial interests in Merck.
 
This course is no longer available to take.

 


 
Supported by an unrestricted educational grant from
Abbott Immunology